TLR4 agonists as emerging adjuvants for sublingual allergen immunotherapy: Preclinical evidence and future perspectives. // American Journal of Emergency Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1323893026001267?dgcid=rss_sd_all
TLR4 agonists as emerging adjuvants for sublingual allergen immunotherapy: Preclinical evidence and future perspectives. American Journal of Emergency Medicine. https://www.sciencedirect.com/science/article/pii/S1323893026001267?dgcid=rss_sd_all
“TLR4 agonists as emerging adjuvants for sublingual allergen immunotherapy: Preclinical evidence and future perspectives.” American Journal of Emergency Medicine.
@article{article3181,
title = {TLR4 agonists as emerging adjuvants for sublingual allergen immunotherapy: Preclinical evidence and future perspectives},
journal = {American Journal of Emergency Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1323893026001267?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: African Journal of Emergency Medicine, Volume 16, Issue 4 Author(s): Hendry R. Sawe, Said S. Kilindimo, Evelyne G. Mapunda, Gimbo Hyuha, Humphrey Medarakini, Alphonce N. Simbila, Muhanuzi Biita,...
Publication date: December 2026 Source: African Journal of Emergency Medicine, Volume 16, Issue 4 Author(s): Vidya Lalloo, Jan Heystek, André du Plessis
Publication date: December 2026 Source: African Journal of Emergency Medicine, Volume 16, Issue 4 Author(s): Halley J. Alberts, Caroline L. Brady, Grace W. Katha, Laura A. Nolting, Stephen F. Ridley, Patrick Nachipo, Karen Chetcuti,...